| Literature DB >> 33896789 |
Claudio Cannistrà1, Yousuf Al-Shaqsi1.
Abstract
OBJECTIVES: To describe the surgical approach to the treatment of iatrogenic gynecomastia via peri-areolar incision.Entities:
Keywords: Gynecomastia; bicalutamide; hormone therapy; peri-areolar incision; prostate cancer
Mesh:
Year: 2021 PMID: 33896789 PMCID: PMC9149696 DOI: 10.15537/smj.2021.42.5.20200459
Source DB: PubMed Journal: Saudi Med J ISSN: 0379-5284 Impact factor: 1.422
Figure 1- Hormonal therapy after prostate cancer of the 65 year old patient with gynecomastie grade 3. Preoperative marking: point A: reference point on the mid-clavicle about 6 cm from the medial clavicular end; point A-C: a line from the clavicle reference point down to the infra-mammary crease, passing through the nipples; point C: the new nipple site, with a 3-cm areolar diameter, was marked at 16 cm below the reference point on the vertical lines. Skin sensation in the peri-areolar area is evaluated using the pinch test technique; point D: a circular peri-areolar marking was performed, corresponding to the cutaneous region to be resected, a skin incision of about 3 mm was made at 3 o’clock and 9 o’clock. We used a 2-mm cannula to infiltrate the subcutaneous tissue with a mixture of one litre of normal saline, one milligram of adrenaline and 20 millilitres of 1% lidocaine.
Figure 2- Dermal incision after remove of fat by lipoaspiration. Point A-B: dermal areolar pedicle; point C: 2-4 o’clock dermal incision; point D: 8-10 o’clock dermal incision to made excision of the gland.
Figure 3- Result after 6 months.